GE
71
4
EA
42
3
MAR
60
3
BAC
62
5
CCL
65
-3
COST
60
4
EMC
93
8
AVGO
69
5
JPM
69
3
KLAC
70
2
RHI
49
2
CFG
56
2
GS
59
-6
AAPL
55
2
ICE
67
5
EMR
51
3
HCA
44
5
EQT
39
2
ACN
49
2
CA
12
4
GE
71
4
EA
42
3
MAR
60
3
BAC
62
5
CCL
65
-3
COST
60
4
EMC
93
8
AVGO
69
5
JPM
69
3
KLAC
70
2
RHI
49
2
CFG
56
2
GS
59
-6
AAPL
55
2
ICE
67
5
EMR
51
3
HCA
44
5
EQT
39
2
ACN
49
2
CA
12
4
Financhill
Back

Lantern Pharma Vs. Nike Industry Stock Comparison

Sell
41

LTRN
Lantern Pharma

Last Price:
4.53
Seasonality Move:
-2.37%
Sell
17

NKE
Nike

Last Price:
76.06
Seasonality Move:
6.25%
Sell
41
Lantern Pharma (LTRN) is a Sell

Is Lantern Pharma a Buy, Sell or Hold?

  • The current Lantern Pharma [LTRN] share price is $4.40. The Score for LTRN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • LTRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
17
Nike (NKE) is a Sell

Is Nike a Buy, Sell or Hold?

  • The current Nike [NKE] share price is $76.04. The Score for NKE is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • NKE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

LTRN Stock Price Chart

What is Lantern Pharma's stock price today?

  • The Lantern Pharma share price today is $4.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LTRN is experiencing selling pressure, which indicates risk of future bearish movement.

NKE Stock Price Chart

What is Nike's stock price today?

  • The Nike share price today is $76.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKE is experiencing slight selling pressure.

LTRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.44 Sell
Relative Strength Index (14 RSI): 37.57 Sell
Chaikin Money Flow: -20938 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.43 - 6.01) Sell
Bollinger Bands (100): (4.42 - 7.7) Sell

NKE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.2 Sell
Relative Strength Index (14 RSI): 21.68 Sell
Chaikin Money Flow: -4026097 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (86.28 - 98.68) Sell
Bollinger Bands (100): (89.69 - 101.25) Sell

LTRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.3 Buy
20-day SMA: 4.99 Sell
50-day SMA: 5.6 Sell
200-day SMA: 4.88 Sell
8-day EMA: 4.5 Sell
20-day EMA: 4.89 Sell
50-day EMA: 5.48 Sell
200-day EMA: 5.35 Sell

NKE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 88.2 Sell
20-day SMA: 92.27 Sell
50-day SMA: 92.61 Sell
200-day SMA: 100.01 Sell
8-day EMA: 85 Sell
20-day EMA: 89.87 Sell
50-day EMA: 92.49 Sell
200-day EMA: 99.26 Sell

Lantern Pharma Earnings Growth & LTRN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.59 per share, and an increase next year of $0.24 per share.

Nike Earnings Growth & NKE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.48 per share, and a decrease next year of $0.52 per share.

Lantern Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nike Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):